97 related articles for article (PubMed ID: 7988721)
41. The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein.
Margheri F; D'Alessio S; Serratì S; Pucci M; Del Rosso A; Benelli R; Ferrari N; Noonan DM; Albini A; Fibbi G; Del Rosso M
Int J Oncol; 2005 Jul; 27(1):223-35. PubMed ID: 15942664
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of endothelial cell movement and tubulogenesis by human recombinant soluble melanotransferrin: involvement of the u-PAR/LRP plasminolytic system.
Michaud-Levesque J; Rolland Y; Demeule M; Bertrand Y; Béliveau R
Biochim Biophys Acta; 2005 Apr; 1743(3):243-53. PubMed ID: 15843038
[TBL] [Abstract][Full Text] [Related]
43. Amino-terminal fragment of urokinase-type plasminogen activator inhibits HIV-1 replication.
Wada M; Wada NA; Shirono H; Taniguchi K; Tsuchie H; Koga J
Biochem Biophys Res Commun; 2001 Jun; 284(2):346-51. PubMed ID: 11394884
[TBL] [Abstract][Full Text] [Related]
44. Urokinase-mediated transactivation of the plasminogen activator inhibitor type 2 (PAI-2) gene promoter in HT-1080 cells utilises AP-1 binding sites and potentiates phorbol ester-mediated induction of endogenous PAI-2 mRNA.
Dear AE; Costa M; Medcalf RL
FEBS Lett; 1997 Feb; 402(2-3):265-72. PubMed ID: 9037208
[TBL] [Abstract][Full Text] [Related]
45. Modulation of invasive properties of human glioblastoma cells stably expressing amino-terminal fragment of urokinase-type plasminogen activator.
Mohanam S; Chandrasekar N; Yanamandra N; Khawar S; Mirza F; Dinh DH; Olivero WC; Rao JS
Oncogene; 2002 Nov; 21(51):7824-30. PubMed ID: 12420219
[TBL] [Abstract][Full Text] [Related]
46. The urokinase receptor is a major vitronectin-binding protein on endothelial cells.
Kanse SM; Kost C; Wilhelm OG; Andreasen PA; Preissner KT
Exp Cell Res; 1996 May; 224(2):344-53. PubMed ID: 8612711
[TBL] [Abstract][Full Text] [Related]
47. Immunohistochemical localization of urokinase-type plasminogen activator, type-1 plasminogen-activator inhibitor, urokinase receptor and alpha(2)-macroglobulin receptor in human breast carcinomas.
Christensen L; Wiborg Simonsen AC; Heegaard CW; Moestrup SK; Andersen JA; Andreasen PA
Int J Cancer; 1996 May; 66(4):441-52. PubMed ID: 8635858
[TBL] [Abstract][Full Text] [Related]
48. Assembly of urokinase receptor-mediated plasminogen activation complexes involves direct, non-active-site interactions between urokinase and plasminogen.
Ellis V; Whawell SA; Werner F; Deadman JJ
Biochemistry; 1999 Jan; 38(2):651-9. PubMed ID: 9888805
[TBL] [Abstract][Full Text] [Related]
49. Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator.
Sitter T; Toet K; Quax P; Kooistra T
Kidney Int; 1999 Jan; 55(1):120-9. PubMed ID: 9893120
[TBL] [Abstract][Full Text] [Related]
50. Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes.
Stoppelli MP; Corti A; Soffientini A; Cassani G; Blasi F; Assoian RK
Proc Natl Acad Sci U S A; 1985 Aug; 82(15):4939-43. PubMed ID: 2991901
[TBL] [Abstract][Full Text] [Related]
51. Up-regulation of urokinase and urokinase receptor genes in malignant astrocytoma.
Gladson CL; Pijuan-Thompson V; Olman MA; Gillespie GY; Yacoub IZ
Am J Pathol; 1995 May; 146(5):1150-60. PubMed ID: 7747809
[TBL] [Abstract][Full Text] [Related]
52. Pro-urokinase up-regulates the expression of urokinase-type plasminogen activator (u-PA) in human pulmonary arterial endothelial cells.
Liu Y; Wang C; Yang Y; Hou X; Wang J
Thromb Res; 2008; 121(4):485-91. PubMed ID: 17640719
[TBL] [Abstract][Full Text] [Related]
53. Role of urokinase and its receptor in basal and stimulated colonic epithelial cell migration in vitro.
Wilson AJ; Gibson PR
Gut; 2000 Jul; 47(1):105-11. PubMed ID: 10861271
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of prostate cancer neovascularization and growth by urokinase-plasminogen activator receptor blockade.
Evans CP; Elfman F; Parangi S; Conn M; Cunha G; Shuman MA
Cancer Res; 1997 Aug; 57(16):3594-9. PubMed ID: 9270033
[TBL] [Abstract][Full Text] [Related]
55. Fluorescent probes as tools to assess the receptor for the urokinase-type plasminogen activator on tumor cells.
Schmitt M; Chucholowski N; Busch E; Hellmann D; Wagner B; Goretzki L; Jänicke F; Günzler WA; Graeff H
Semin Thromb Hemost; 1991 Jul; 17(3):291-302. PubMed ID: 1724574
[TBL] [Abstract][Full Text] [Related]
56. Epitope mapping of the anti-urokinase monoclonal antibody 5B4 by isolated domains of urokinase.
Corti A; Sarubbi E; Soffientini A; Nolli ML; Zanni A; Galimberti M; Parenti F; Cassani G
Thromb Haemost; 1989 Nov; 62(3):934-9. PubMed ID: 2480654
[TBL] [Abstract][Full Text] [Related]
57. Characterization of the binding of urokinase-type plasminogen activator (u-PA) to plasminogen, to plasminogen-activator inhibitor-1 and to the u-PA receptor.
Lijnen HR; De Cock F; Collen D
Eur J Biochem; 1994 Sep; 224(2):567-74. PubMed ID: 7925373
[TBL] [Abstract][Full Text] [Related]
58. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.
Vines DJ; Lee SW; Dichek DA; Ellis V
J Pept Sci; 2000 Sep; 6(9):432-9. PubMed ID: 11016879
[TBL] [Abstract][Full Text] [Related]
59. Prolonged half-life in the circulation of a chemical conjugate between a pro-urokinase derivative and human serum albumin.
Breton J; Pezzi N; Molinari A; Bonomini L; Lansen J; Gonzalez De Buitrago G; Prieto I
Eur J Biochem; 1995 Aug; 231(3):563-9. PubMed ID: 7649155
[TBL] [Abstract][Full Text] [Related]
60. A hybrid protein of the amino-terminal fragment of urokinase and mutant plasminogen activator inhibitor-2 efficiently inhibits tumor cell invasion and metastasis.
Wang X; Hou M; Tan L; Sun X; Zhang Y; Li P; Zhu Y
J Cancer Res Clin Oncol; 2005 Feb; 131(2):129-36. PubMed ID: 15490235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
